The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers.
Ontology highlight
ABSTRACT: RimK-like family member B (RIMKLB) is an enzyme that post-translationally modulates ribosomal protein S6, which can affect the development of immune cells. Some studies have suggested its role in tumor progression. However, the relationships among RIMKLB expression, survival outcomes, and tumor-infiltrating immune cells (TIICs) in colorectal cancer (CRC) are still unknown. Therefore, we analyzed RIMKLB expression levels in CRC and normal tissues and investigated the correlations between RIMKLB and TIICs as well as the impact of RIMKLB expression on clinical prognosis in CRC using multiple databases, including the Tumor Immune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), PrognoScan, and UALCAN databases. Enrichment analysis was conducted with the clus
SUBMITTER: Cao Y
PROVIDER: S-EPMC9015428 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA